Serum CXCL10/IP-10 may be a potential biomarker for severe Mycoplasma pneumoniae pneumonia in children

BACKGROUND: How to early distinguish the severity of Mycoplasma pneumoniae pneumonia (MPP) is a worldwide concern in clinical practice. We therefore conducted this study to assess the relationship between levels of serum inflammatory chemokines and the severity of MPP. METHODS: In this prospective s...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Mengyao, Chen, Ying, Li, Huihan, Yang, Dehua, Zhou, Yunlian, Chen, Zhimin, Zhang, Yuanyuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8418284/
https://www.ncbi.nlm.nih.gov/pubmed/34481469
http://dx.doi.org/10.1186/s12879-021-06632-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8418284/
https://www.ncbi.nlm.nih.gov/pubmed/34481469
http://dx.doi.org/10.1186/s12879-021-06632-4

Ejemplares similares